Written for dentists working in general, family and cosmetic dentistry, as well as specialists from all disciplines, Decisions in Dentistry is a peer-reviewed journal designed to support the highest standards of professionalism and integrity in multidisciplinary care. Reflecting the latest thinking from nationally ranked educators, researchers and clinicians, the journal presents evidence-based, clinically relevant articles in an inviting and easy-to-understand format. Unique in its approach, Decisions in Dentistry makes the complex simple and offers unbiased information and continuing education that dentists can use to improve their technique and provide the highest level of care.
Pulpdent has been awarded two U.S. patents for a bioactive, stabilized calcium phosphate molecule that is said to facilitate tooth remineralization, promote hydroxyapatite formation, and offer excellent esthetics.
University of the Pacific, Arthur A. Dugoni School of Dentistry is expanding ways to train oral healthcare providers to care for underserved people with intellectual and developmental disabilities (IDD) from a wide range of backgrounds.…
Parkell is proud to announce the new Brush&Bond® MAX bonding system. Building on decades of success with Brush&Bond, Brush&Bond MAX is a next-generation bonding agent that focuses on providing optimal performance on the surfaces…
Better days are ahead as the number of new COVID-19 cases continues to drop across the United States. In response, some states—including California—are beginning to loosen or strike down indoor mask mandates. On February 16, vaccinated…
National World Cancer Day fell on February 4 this year. In recognition, OraCare created the “Your Order, Their Relief " program, which donates a complimentary set of OraCare Rinse products to patients undergoing cancer therapy every time…
W&H Group, a leading international medical technology company, will unveil its latest innovations and solutions for dentists and clinicians at the Chicago Dental Society 2022 Midwinter Meeting. This national convention takes place…
A partnership between the Organization for Safety, Asepsis and Prevention and U.S. Centers for Disease Control and Prevention (CDC) has spawned new opportunities for ongoing training in infection prevention protocols.
A study by Oxford University and the National Institute for Health Research in the United Kingdom has found that 37% of those who have recovered from COVID-19 still experience at least one side effect three to six months later.